{"id":401619,"date":"2020-12-17T07:03:26","date_gmt":"2020-12-17T12:03:26","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=401619"},"modified":"2020-12-17T07:03:26","modified_gmt":"2020-12-17T12:03:26","slug":"quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/","title":{"rendered":"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <strong>QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POC<sup>TM<\/sup> device and disposable test cassette <\/strong>\n      <\/p>\n<p align=\"center\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0&#8211;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>Q-POC\u2122 is a point of care molecular diagnostic system which delivers results in approximately 30 minutes; first application in COVID-19<\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>\u00a0<\/strong><br \/>NEWCASTLE UPON TYNE, UK, 17 December 2020. QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over \u00a311 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC\u2122 and disposable test cassette.<\/p>\n<p>QuantuMDx accelerated development, scale-up and manufacture of Q-POC\u2122 &#8211; its rapid point-of-care testing system &#8211; earlier this year in response to the COVID-19 pandemic.<\/p>\n<p>Q-POC\u2122 is a portable, PCR device offering rapid, sample-to-answer, molecular diagnostic testing at the point of care, with results in approximately 30 minutes. The Q-POC\u2122 system comprises a sample collection kit, single-use test cassette and analyser.<\/p>\n<p>The company\u2019s first commercial assay for Q-POC\u2122 will detect SARS-CoV-2, the virus causing COVID-19, and Flu A &amp; B, providing a powerful rapid PCR diagnostics and surveillance tool for clinicians and public health officials.<\/p>\n<p>QuantuMDx has worked with British development partner Cambridge Design Partnership to undertake pilot manufacturing of Q-POC\u2122, and are now working with Cogent Technology, as the company scales for volume manufacturing.<\/p>\n<p>Cogent Technology operate a 80,000 sq feet facility in Felixstowe, U.K. and have procured a new surface mount assembly line, specifically for QuantuMDx, which includes a state-of-the-art Automated Optical Inspection machine, currently the only one available in the U.K.<\/p>\n<p>Rapid scale-up manufacturing of QuantuMDx\u2019s SARS CoV-2 Flu A\/B disposable test cassettes is also taking place. QuantuMDx has worked with development partner, RD Support from concept, through design and optimisation, to pilot manufacture in Denmark and design transfer to Singapore-based high volume manufacturer, Univac.<\/p>\n<p>Univac is in the final stages of establishing a two million cassette production line, manufacturing component parts (injection mould tooling) undertaking assembly and inspection, as well as validating the production line, processes and equipment. Univac will manufacture the first batch of test cassettes in early 2021.<\/p>\n<p>QuantuMDx expects to achieve CE-IVD marking for its Q-POC\u2122 system in early 2021, following a release for research use only<em>.<\/em><\/p>\n<p>\n        <strong>Jonathan O\u2019Halloran, Chief Executive, QuantuMDx, said:<\/strong>\n      <\/p>\n<p>\u201cWe have developed the Q-POC\u2122 over the past 10 years and created one of the fastest, most accurate and powerful PCR diagnostic devices on the market, and at the right time to be able to respond to the pandemic. We have spent the last 10 months scaling our manufacturing for both our Q-POC\u2122 and first commercial test cassette and are presently running performance evaluation studies to confirm performance in real-life clinical settings.<\/p>\n<p>\u201cWe\u2019re delighted to be working with Univac, RD Support and fellow British partners, Cogent and CDP to support the international response to COVID-19 testing. Scaling-up was always going to be a challenge, especially during a global pandemic, but with the commitment, focus and dedication of everyone involved with QuantuMDx and our partners, we\u2019ll soon be able to introduce our rapid, point of care diagnostic solution to benefit front line health workers, across the globe. With the large manufacturing scale that we have achieved, QuantuMDx is poised to become an important player in the molecular diagnostics industry.\u201d<\/p>\n<p>###<\/p>\n<p align=\"justify\">\n        <strong>About QuantuMDx: <\/strong>\n      <\/p>\n<p>QuantuMDx Group is an ambitious company with a global vision of empowering the world to control and eradicate disease by making transformative, quality point-of-care diagnostic technologies universally accessible. QuantuMDx has operations and strategic partnerships in the United States, Asia, Australasia, Europe and Africa \u2013 keeping it at the forefront of molecular diagnostics. For more information go to: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HZ83BgxjREbmn8zPEIGYcPCVLzsTPn2_c-GV7rvr6AnuhR8OI2zOrFXzzgydGhL9Uo8qqFom7XJo3LrkNVAl1s9HECUVwWHUxLpZyoPARbo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.quantumdx.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>For media enquiries: <\/strong>\n      <\/p>\n<p align=\"justify\">Debra Daglish, Marketing Communications Manager, QuantuMDx Group, 0870 803 1234<\/p>\n<p>Chris Gardner, Matthew Neal and Lindsey Neville, <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-8DAbk-hcM4pe9jJu4UEKpq54x3Zgdk8itS5lxl5tpRKJvBhlkypTdVXtCJTt-ShlMgJEyH-Ia6Hg8mr6EY2f0smIzE7RF6tnqij2ddbtT4Aeiqefroy8LQ8HcTUXMte\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Consilium Strategic Communications<\/a><\/u>, 0203 709 5700\/ <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KDrWH0J4zmivgXbW2gRF3O1UHz6g4QRtQ6mMehTGXjufIuEPksHnSMqk0JAtUpI82rFbAmjBYC2q_ppPZbxO8LmAkCi--B7YViEeL3qIA6DQmBDSRiaPV2TsOV7sI2sG\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">quantumdx@consilium-comms.com<\/a><\/u><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/b94b1883-429e-4572-af09-66c04c6d6f80\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0&#8211;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Q-POC\u2122 is a point of care molecular diagnostic system which delivers results in approximately 30 minutes; first application in COVID-19\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NEWCASTLE UPON TYNE, UK, 17 December 2020. QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over \u00a311 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC\u2122 and disposable test cassette. QuantuMDx accelerated development, scale-up and manufacture of Q-POC\u2122 &#8211; its rapid point-of-care testing system &#8211; earlier this year in response to the COVID-19 pandemic. Q-POC\u2122 is a portable, PCR device offering rapid, sample-to-answer, molecular diagnostic testing at the point &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-401619","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0&#8211;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Q-POC\u2122 is a point of care molecular diagnostic system which delivers results in approximately 30 minutes; first application in COVID-19\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NEWCASTLE UPON TYNE, UK, 17 December 2020. QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over \u00a311 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC\u2122 and disposable test cassette. QuantuMDx accelerated development, scale-up and manufacture of Q-POC\u2122 &#8211; its rapid point-of-care testing system &#8211; earlier this year in response to the COVID-19 pandemic. Q-POC\u2122 is a portable, PCR device offering rapid, sample-to-answer, molecular diagnostic testing at the point &hellip; Continue reading &quot;QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-17T12:03:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette\",\"datePublished\":\"2020-12-17T12:03:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/\"},\"wordCount\":626,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/\",\"name\":\"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5\",\"datePublished\":\"2020-12-17T12:03:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/","og_locale":"en_US","og_type":"article","og_title":"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette - Market Newsdesk","og_description":"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0&#8211;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Q-POC\u2122 is a point of care molecular diagnostic system which delivers results in approximately 30 minutes; first application in COVID-19\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NEWCASTLE UPON TYNE, UK, 17 December 2020. QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over \u00a311 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC\u2122 and disposable test cassette. QuantuMDx accelerated development, scale-up and manufacture of Q-POC\u2122 &#8211; its rapid point-of-care testing system &#8211; earlier this year in response to the COVID-19 pandemic. Q-POC\u2122 is a portable, PCR device offering rapid, sample-to-answer, molecular diagnostic testing at the point &hellip; Continue reading \"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-17T12:03:26+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette","datePublished":"2020-12-17T12:03:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/"},"wordCount":626,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/","name":"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5","datePublished":"2020-12-17T12:03:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NjM0MSM0MDA4Mzk0NjQjNzAwMDExODM5"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantumdx-embarks-on-11-million-scale-up-to-mass-manufacture-its-diagnostic-q-poctm-device-and-disposable-test-cassette\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"QuantuMDx embarks on \u00a311 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=401619"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401619\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=401619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=401619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=401619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}